Literature DB >> 1670220

Pancreaticoduodenectomy for malignant pancreatic and periampullary neoplasms in elderly patients.

R Delcore1, J H Thomas, A S Hermreck.   

Abstract

Forty-two patients (age range: 70 to 86 years) underwent pancreaticoduodenectomy between 1970 and 1990 for carcinomas of the pancreas (23), ampulla (8), common bile duct (5), duodenum (5), or islet cells (1). After resection, reconstruction was done by either pancreaticojejunostomy (13) or pancreaticogastrostomy (25); four patients had total pancreatectomy. The mean duration of operation was 5 hours, the mean blood loss was 2,200 mL, the mean transfusion requirement was 4 units of blood, and mean length of hospitalization was 22 days. There were no leaks or other complications related to the pancreatic anastomoses. Six (14%) major complications occurred including two (5%) operative deaths. Mean survival was 42 months (range: 2 to 219 months) for the entire group and 35 months for patients over the age of 80. This experience suggests: (1) pancreaticoduodenectomy can be performed with low operative morbidity and mortality in elderly patients, and advanced age should not be considered a contrainindication to this potentially curative procedure; (2) pancreaticogastrostomy is a safe and easy alternate method of reconstruction; and (3) prolonged survival is possible for elderly patients following pancreaticoduodenectomy for malignant pancreatic and periampullary neoplasms.

Entities:  

Mesh:

Year:  1991        PMID: 1670220     DOI: 10.1016/0002-9610(91)90104-l

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Authors:  M Carpelan-Holmström; S Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; C Haglund
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 2.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

Review 3.  Pancreatic adenocarcinoma: why and when should it be resected?

Authors:  D Ravichandran; C D Johnson
Journal:  Postgrad Med J       Date:  1997-08       Impact factor: 2.401

4.  Anatomy of a practice guideline. Tradition, science, and consensus on using electrocardiograms in Saskatchewan. Health Services Utilization and Research Commission.

Authors: 
Journal:  Can Fam Physician       Date:  1995-01       Impact factor: 3.275

5.  Risk by indication for pancreaticoduodenectomy in patients 80 years and older: a study from the American College of Surgeons National Surgical Quality Improvement Program.

Authors:  John R Bergquist; Christopher R Shubert; Daniel S Ubl; Cornelius A Thiels; Michael L Kendrick; Mark J Truty; Elizabeth B Habermann
Journal:  HPB (Oxford)       Date:  2016-09-01       Impact factor: 3.647

6.  Outcome after pancreaticoduodenectomy for cancer in elderly patients.

Authors:  Radu Scurtu; Philippe Bachellier; Elie Oussoultzoglou; Edoardo Rosso; Rodrigo Maroni; Daniel Jaeck
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

7.  Clinical outcomes of pancreaticoduodenectomy in octogenarians: a surgeon's experience from 2007 to 2015.

Authors:  Diana H Liang; Beverly A Shirkey; Wade R Rosenberg; Sylvia Martinez
Journal:  J Gastrointest Oncol       Date:  2016-08

8.  The safety of a pancreaticoduodenectomy in patients older than 80 years: risk vs. benefits.

Authors:  Marcovalerio Melis; Francesca Marcon; Antonio Masi; Antonio Pinna; Umut Sarpel; George Miller; Harvey Moore; Steven Cohen; Russell Berman; H Leon Pachter; Elliot Newman
Journal:  HPB (Oxford)       Date:  2012-05-29       Impact factor: 3.647

9.  Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.

Authors:  Jonathan E Lim; Michael W Chien; Craig C Earle
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

10.  Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.

Authors:  Sunil Amin; Aimee L Lucas; Harold Frucht
Journal:  Pancreas       Date:  2013-03       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.